Análisis de los fenotipos y genotipos de resistencia a eritromicina y clindamicina en cepas de Streptococcus pyogenes aisladas en Chile en un período de 10 años

Background: Macrolide and lincosamide resistance in Streptococcus pyogenes is due to the acquisition of mef, ermB and ermA genes, which confer different resistance phenotypes, namely M, MLSBconstitutive and MLSBinducible respectively. The last report of resistance in Chile was done in the period 199...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rodríguez,Carlos, Rojas,Pablo, Wozniak,Aniela, Kalergis,Alexis M, Cerón,Inés, Riedel,Ingrid, Román,Juan C, Villarroel,Luis A, Berríos,Ximena, Bavestrello,Luis, García,Patricia
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2011
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872011000900005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872011000900005
record_format dspace
spelling oai:scielo:S0034-988720110009000052011-11-17Análisis de los fenotipos y genotipos de resistencia a eritromicina y clindamicina en cepas de Streptococcus pyogenes aisladas en Chile en un período de 10 añosRodríguez,CarlosRojas,PabloWozniak,AnielaKalergis,Alexis MCerón,InésRiedel,IngridRomán,Juan CVillarroel,Luis ABerríos,XimenaBavestrello,LuisGarcía,Patricia Drug resistance, bacterial Genetic markers Streptococcus pyogenes Background: Macrolide and lincosamide resistance in Streptococcus pyogenes is due to the acquisition of mef, ermB and ermA genes, which confer different resistance phenotypes, namely M, MLSBconstitutive and MLSBinducible respectively. The last report of resistance in Chile was done in the period 1990-1998, in which resistance to macrolides was 5.4%, with M phenotype as the predominant one. Aim: To characterize the evolution of erythromycin and clindamycin resistance and their associated genes in S. pyogenes strains isolated from patients with invasive and non-invasive infections in the period 1996 to 2005. Material and Methods: Resistance to erythromycin and clindamycin was determined in 1,282 clinical isolates using the disk diffusion test. Resistant isolates were analyzed by polymerase chain reaction (PCR) for the presence of the above mentioned resistance genes. Results: Global resistance to erythromycin and clindamycin was 3.5 and 0.7% respectively. Eighty percent of the resistant strains possessed the M. phenotype. Conclusions: Resistance levels of S. pyogenes have decreased in Chile in the last years. Most resistant strains have M phenotype in contrast to many countries in which the MLSB constitutive phenotype is the predominant one.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.139 n.9 20112011-09-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872011000900005es10.4067/S0034-98872011000900005
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Drug resistance, bacterial
Genetic markers
Streptococcus pyogenes
spellingShingle Drug resistance, bacterial
Genetic markers
Streptococcus pyogenes
Rodríguez,Carlos
Rojas,Pablo
Wozniak,Aniela
Kalergis,Alexis M
Cerón,Inés
Riedel,Ingrid
Román,Juan C
Villarroel,Luis A
Berríos,Ximena
Bavestrello,Luis
García,Patricia
Análisis de los fenotipos y genotipos de resistencia a eritromicina y clindamicina en cepas de Streptococcus pyogenes aisladas en Chile en un período de 10 años
description Background: Macrolide and lincosamide resistance in Streptococcus pyogenes is due to the acquisition of mef, ermB and ermA genes, which confer different resistance phenotypes, namely M, MLSBconstitutive and MLSBinducible respectively. The last report of resistance in Chile was done in the period 1990-1998, in which resistance to macrolides was 5.4%, with M phenotype as the predominant one. Aim: To characterize the evolution of erythromycin and clindamycin resistance and their associated genes in S. pyogenes strains isolated from patients with invasive and non-invasive infections in the period 1996 to 2005. Material and Methods: Resistance to erythromycin and clindamycin was determined in 1,282 clinical isolates using the disk diffusion test. Resistant isolates were analyzed by polymerase chain reaction (PCR) for the presence of the above mentioned resistance genes. Results: Global resistance to erythromycin and clindamycin was 3.5 and 0.7% respectively. Eighty percent of the resistant strains possessed the M. phenotype. Conclusions: Resistance levels of S. pyogenes have decreased in Chile in the last years. Most resistant strains have M phenotype in contrast to many countries in which the MLSB constitutive phenotype is the predominant one.
author Rodríguez,Carlos
Rojas,Pablo
Wozniak,Aniela
Kalergis,Alexis M
Cerón,Inés
Riedel,Ingrid
Román,Juan C
Villarroel,Luis A
Berríos,Ximena
Bavestrello,Luis
García,Patricia
author_facet Rodríguez,Carlos
Rojas,Pablo
Wozniak,Aniela
Kalergis,Alexis M
Cerón,Inés
Riedel,Ingrid
Román,Juan C
Villarroel,Luis A
Berríos,Ximena
Bavestrello,Luis
García,Patricia
author_sort Rodríguez,Carlos
title Análisis de los fenotipos y genotipos de resistencia a eritromicina y clindamicina en cepas de Streptococcus pyogenes aisladas en Chile en un período de 10 años
title_short Análisis de los fenotipos y genotipos de resistencia a eritromicina y clindamicina en cepas de Streptococcus pyogenes aisladas en Chile en un período de 10 años
title_full Análisis de los fenotipos y genotipos de resistencia a eritromicina y clindamicina en cepas de Streptococcus pyogenes aisladas en Chile en un período de 10 años
title_fullStr Análisis de los fenotipos y genotipos de resistencia a eritromicina y clindamicina en cepas de Streptococcus pyogenes aisladas en Chile en un período de 10 años
title_full_unstemmed Análisis de los fenotipos y genotipos de resistencia a eritromicina y clindamicina en cepas de Streptococcus pyogenes aisladas en Chile en un período de 10 años
title_sort análisis de los fenotipos y genotipos de resistencia a eritromicina y clindamicina en cepas de streptococcus pyogenes aisladas en chile en un período de 10 años
publisher Sociedad Médica de Santiago
publishDate 2011
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872011000900005
work_keys_str_mv AT rodriguezcarlos analisisdelosfenotiposygenotiposderesistenciaaeritromicinayclindamicinaencepasdestreptococcuspyogenesaisladasenchileenunperiodode10anos
AT rojaspablo analisisdelosfenotiposygenotiposderesistenciaaeritromicinayclindamicinaencepasdestreptococcuspyogenesaisladasenchileenunperiodode10anos
AT wozniakaniela analisisdelosfenotiposygenotiposderesistenciaaeritromicinayclindamicinaencepasdestreptococcuspyogenesaisladasenchileenunperiodode10anos
AT kalergisalexism analisisdelosfenotiposygenotiposderesistenciaaeritromicinayclindamicinaencepasdestreptococcuspyogenesaisladasenchileenunperiodode10anos
AT ceronines analisisdelosfenotiposygenotiposderesistenciaaeritromicinayclindamicinaencepasdestreptococcuspyogenesaisladasenchileenunperiodode10anos
AT riedelingrid analisisdelosfenotiposygenotiposderesistenciaaeritromicinayclindamicinaencepasdestreptococcuspyogenesaisladasenchileenunperiodode10anos
AT romanjuanc analisisdelosfenotiposygenotiposderesistenciaaeritromicinayclindamicinaencepasdestreptococcuspyogenesaisladasenchileenunperiodode10anos
AT villarroelluisa analisisdelosfenotiposygenotiposderesistenciaaeritromicinayclindamicinaencepasdestreptococcuspyogenesaisladasenchileenunperiodode10anos
AT berriosximena analisisdelosfenotiposygenotiposderesistenciaaeritromicinayclindamicinaencepasdestreptococcuspyogenesaisladasenchileenunperiodode10anos
AT bavestrelloluis analisisdelosfenotiposygenotiposderesistenciaaeritromicinayclindamicinaencepasdestreptococcuspyogenesaisladasenchileenunperiodode10anos
AT garciapatricia analisisdelosfenotiposygenotiposderesistenciaaeritromicinayclindamicinaencepasdestreptococcuspyogenesaisladasenchileenunperiodode10anos
_version_ 1718436585770319872